In mice, A-FABP deficiency ameliorates the development of insulin resistance in diet-induced obesity [2], type 2 diabetes [6], and atherosclerosis in models of hypercholesterolemia [7]. Here, FABP4 is linked to type 2 diabetes mellitus.